Globus Medical (NYSE:GMED) EVP Kelly Huller Sells 10,000 Shares

Globus Medical, Inc. (NYSE:GMED) EVP Kelly Huller sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $87.67, for a total value of $876,700.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Kelly Huller also recently made the following trade(s):

• On Tuesday, November 25th, Kelly Huller sold 7,500 shares of Globus Medical stock. The stock was sold at an average price of $90.00, for a total value of $675,000.00.

Globus Medical Trading Up 1.0%

NYSE GMED opened at $89.01 on Wednesday. The business has a fifty day simple moving average of $89.68 and a 200 day simple moving average of $74.55. Globus Medical, Inc. has a 12 month low of $51.79 and a 12 month high of $101.40. The firm has a market capitalization of $11.91 billion, a P/E ratio of 28.71, a PEG ratio of 1.35 and a beta of 1.06.

Hedge Funds Weigh In On Globus Medical

Several hedge funds and other institutional investors have recently modified their holdings of the company. Paradice Investment Management LLC lifted its holdings in shares of Globus Medical by 20.9% during the third quarter. Paradice Investment Management LLC now owns 663,038 shares of the medical device company’s stock worth $37,972,000 after buying an additional 114,433 shares in the last quarter. Allspring Global Investments Holdings LLC increased its position in Globus Medical by 189.9% during the third quarter. Allspring Global Investments Holdings LLC now owns 476,531 shares of the medical device company’s stock worth $27,953,000 after acquiring an additional 312,149 shares during the period. Campbell & CO Investment Adviser LLC bought a new position in Globus Medical during the third quarter worth about $539,000. Foresight Group Ltd Liability Partnership raised its stake in Globus Medical by 160.7% in the 3rd quarter. Foresight Group Ltd Liability Partnership now owns 421,541 shares of the medical device company’s stock worth $24,142,000 after purchasing an additional 259,870 shares in the last quarter. Finally, Lightrock Netherlands B.V. boosted its holdings in Globus Medical by 6.2% in the 3rd quarter. Lightrock Netherlands B.V. now owns 251,900 shares of the medical device company’s stock valued at $14,426,000 after purchasing an additional 14,750 shares during the period. 95.16% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on GMED shares. Truist Financial restated a “buy” rating and issued a $105.00 price objective (up from $93.00) on shares of Globus Medical in a research report on Tuesday, November 18th. Royal Bank Of Canada increased their target price on shares of Globus Medical from $92.00 to $100.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Citigroup restated a “market perform” rating on shares of Globus Medical in a research report on Thursday, January 8th. Canaccord Genuity Group upped their price target on shares of Globus Medical from $105.00 to $112.00 and gave the stock a “buy” rating in a report on Friday, January 9th. Finally, Needham & Company LLC raised Globus Medical from a “hold” rating to a “buy” rating and set a $112.00 price objective for the company in a research note on Friday, January 30th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $100.18.

About Globus Medical

Globus Medical, Inc (NYSE:GMED) is a leading medical device company specializing in musculoskeletal solutions for spine and orthopaedic applications. Founded in 2003 by David C. Paul and headquartered in Audubon, Pennsylvania, the company develops, manufactures and markets implantable devices and surgical instruments designed to treat spinal disorders and promote bone healing. Its product portfolio encompasses solutions for minimally invasive and open surgical procedures, including interbody fusion devices, pedicle screw systems, and biologics used to enhance fusion outcomes.

In addition to its core spine business, Globus Medical has expanded into robotics and navigation systems to support precision and efficiency in the operating room.